Posos, a clinical decision support platform founded in 2017, secured growth financing to enhance its commercial development and expand its user base among healthcare professionals.

Target Information

Posos, founded in 2017 by pharmacist Emmanuel Bilbault and information systems engineer Benjamin Grelié, has developed an innovative clinical decision support platform. After three years of rigorous research and development, the company has harnessed proprietary NLP technology and a cross-referencing search engine to create a solution that provides healthcare professionals with quick and accurate information on drug prescriptions. This is essential for optimal clinical decision-making, enabling physicians to research multiple medications concurrently and to contextualize their responses based on specific patient data.

As a certified medical device, Posos is now utilized by over 85,000 healthcare professionals across five countries. Its solution is seamlessly integrated with popular hospital management software systems, including Hospital Manager, Mediboard, Direct-Consult, Orbis, DxCare, and Diane. This widespread adoption demonstrates the platform's reliability and relevance in today's healthcare landscape.

Industry Overview in the Target’s Specific Country

Posos operates within the rapidly evolving digital services and retail finance sectors of the healthcare industry. The digital health market is expanding, driven by technological advancements, increasing healthcare costs, and

View Source

Similar Deals

Cipio Partners Dawn Health

2026

Growth Equity & Expansion Capital Pharmaceuticals (NEC) Other
Kinnevik Oviva

2025

Growth Equity & Expansion Capital Telemedicine Services Other
ARCHIMED RehabWorks and Primo Group s.r.l.

2023

Growth Equity & Expansion Capital Healthcare Facilities & Services (NEC) Other
Prosperity7 Ventures Insilico Medicine

2023

Growth Equity & Expansion Capital Biopharmaceuticals Other
PC Capital Development Fund II, L.P. Polar

2023

Growth Equity & Expansion Capital Hospitals, Clinics & Primary Care Services Other
Nordic Secondary Fund Norlase

2023

Growth Equity & Expansion Capital Laser Equipment Other

Not specified

invested in

Posos

in 2023

in a Growth Equity & Expansion Capital deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert